Trusted Products and Expertise

Pharmgate’s product portfolio represents more than choices. Our team provides the technical expertise to choose the right product for the right reason and get the results you want.


Investing in Products for Your Protocols

Pharmgate FDA- and USDA-approved manufacturing sites are undergoing multi-million-dollar expansions to satisfy increasing global customer demand. To serve you better, Pharmgate continuously invests in additional registrations and use claims for livestock and poultry products. Post-approval, we engage industry expertise to conduct contract applied research and commercial evaluation trials.

Pharmgate’s secure and verified supply chain, and innovative go-to-market collaborations, deliver reliable, value-driven core products that meet your protocol requirements.

Our technical service and field teams have the production experience to provide practical recommendations in protocol development and implementation.


A Portfolio That Fits Your Protocols

Today’s health protocols require the flexibility to meet evolving disease challenges as well as caregivers’ ability to implement them. By offering multiple options for active ingredients, concentrations, administration routes, and monovalent/bivalent vaccines, Pharmgate’s comprehensive portfolio provides you choices to fit your needs.

A Healthy History of Partnerships

We've been working since 2008 to create strong global partnerships. These partnerships have created a product portfolio that puts livestock health first worldwide.

2008 - 2014
2014 - 2018
2014 - 2018
2014 - 2018
2018 - 2020
2014 - 2018
2018 - 2020
2020 - 2022
2020 - 2022
2020 - 2022
2020 - 2022
2020 - 2022
2020 - 2022
2022 - 2024
2020 - 2022
2022 - 2024

Pharmgate is Founded

Partnered with ECO Animal Health

to make Aivlosin® available in US and Canadian markets for ileitis treatment and control.

Acquired Pennfield Animal Health

and its portfolio of water-soluble medication and medicated article (MA) products.

Acquired ADM's Chlortetracycline (CTC) products

Aivlosin® WSG approved for SRD control

Acquired ProtaTek International

a biologics company with a portfolio including: MycoGard®, CircoGard®, CircoMycoGard®.

Launched Deracin® CTC MA


a unique MLV PRRS vaccine approved by US CVB.

Pennitracin MD & Maxiban™ combination approved

Multiple international vaccine approvals

ZoaShield™ 25% approved

Aivlosin® WSG approved for MHP control

Joined with Virbac

to introduce Tulissin®-25, Tulissin® 100, Tia12.5® Tenotryl®

Pennitracin MD & Coban™ combination approved

Pennitracin MD

approved for the prevention of mortality by necrotic enteritis.

Pennchlor® and Rumensin® combinations approved

Aivlosin® WSG Sow restriction removed

and Pennchlor® Rumensin Supplemental Claims approved.